ESC 365 - Biomarker-driven anti-inflammatory therapies for cardiovascular disease: state of the art.

HFA Premium Access

Biomarker-driven anti-inflammatory therapies for cardiovascular disease: state of the art.

Session: Inflammation: cause or consequence of cardiovascular disease? or both?

Topic: Leukocytes, Inflammation, Immunity

Speaker: Professor T. Luescher (London, GB)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Professor Thomas Felix Luescher

Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

52 presentations

5 followers

2 more presentations in this session

Leukocytes link local and systemic inflammation in ischaemic cardiovascular disease: an expanded 'cardiovascular continuum'.

Speaker: Professor F. Leuschner (Heidelberg, DE)

Systemic inflammation and heart failure: lessons from rheumatoid arthritis.

Speaker: Doctor S. Toldo (Richmond, US)

Access the full session

Inflammation: cause or consequence of cardiovascular disease? or both?

Speakers: Professor T. Luescher, Professor F. Leuschner, Doctor S. Toldo

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources